ALS Standard of Care Consensus
Neurol 48 (Suppl 4) :S33-S37997., Miller,R.G.,et al, 1997
Effect of Noninvasive Positive-Pressure Ventilation on Survival in Amyotrophic Lateral Sclerosis
Ann Int Med 127:450-453, Aboussouan,L.S.,et al, 1997
Practice Advisory on the Trtm of ALS with Riluzole
Quality Standards Subcommittee of the AAN, Neurol 49:657-6591997., , 1997
Riluzole
Lancet 348:795-799, Wokke,J., 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996
Dose-Ranging Study of Riluzole in Amyotrophic Lateral Sclerosis
Lancet 347:1425-1431, Lacomblez,L.,et al, 1996
Motor Neuron Disease
BMJ 313:244, Shneerson,J.M., 1996
Multifocal Motor Neuropathy with Conduction Block:A Study of 24 Patients
JNNP 59:38-44, Bouche,P.,et al, 1995
Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Intravenous Immunoglobulin Trtm in Pts with Motor Neuron Syndromes Assoc with Anti-GM Antibodies:A Contrld Study
Neurol 44:429-432, Azulay,J-P.,et al, 1994
Motor Neuron Disease
JNNP 57:886-896, Leigh,P.N.&Ray-Chaudhuri,K., 1994
Recent Developments in the Drug Treatment of Motor Neurone Disease
BMJ 309:140-141, , 1994
Home Ventilation for ALS Patients:Outcomes, Costs, and Patient, Family and Physician Attitudes
Neurol 43:438-443, Moss,A.H.,et al, 1993
Competent Pts with Adv States of Perm Paralysis Have the Right to Forgo Life-Sustaining Therapy
Neurol 43:224-225, Bernat,J.L.,et al, 1993
Multifocal Demyelinating Motor Neuropathy:Cranial Nerve Involvement and Immunoglobulin Therapy
Neurol 42:506-509, Kaji,R.,et al, 1992
Surgical Treatment of Cervical Spondylotic Myelopathy:Time for a Controlled Trial
Neurol 42:5-13, Rowland,L.P., 1992
Motor Neurone Disease
BMJ 304:459-460, Norris,F.H., 1992
Motor Neurone Disease:A Hospice Perspective
BMJ 304:471-473, O'Brien,T.,et al, 1992
Subacute, Reversible Motor Neuron Disease
Neurol 41:1541-1544, Tucker,T.,et al, 1991
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
The Spectrum of Neurologic Disease Associated with Anti-GM1 Antibodies
Neurol 40:1067-1072, Sadiq,S.A.,et al, 1990
Paraneoplastic Motor Neuron Disease and Renal Cell Carcinoma:Improvement after Nephrectomy
Neurol 40:960-962, Evans,B.K.,et al, 1990
Lower Motor Neuron Disease in a Patient with Autoantibodies Against Gangliosides GM1 and GD1b:Improvement with Immunotherapy
Neurol 40:842-844, Shy,M.E.,et al, 1990
Respiratory Complications and Their Management in Motor Neuron Disease
Brain 112:1155-1170, Howard,R.S.,et al, 1989
Amyotrophic Lateral Sclerosis, Recent Advances in Pathogenesis & Therapeutic Trials
Arch Neurol 45:189-202, Mitsumoto,H.,et al, 1988
The Molecular Genetic Revolution, Its Impact on Clinical Neurology
Arch Neurol 45:1366-1376, Payne,C.S.&Roses,A.D., 1988
Current Status of Thyrotropin-Releasing Hormone Therapy in Amyotrophic Lateral Sclerosis
Comm. on Health Care Issues, Amer Neuro Assoc, Ann Neurol 22:541-54387., , 1987
Diaphragm Pacing for Ventilatory Insufficiency
J Inten Care Med 2:345-353, Marcy,T.W.&Loke,J.S., 1987
A Double-Blind, Placebo-Controlled Trial of TRH in Amyotrophic Lateral Sclerosis
Neurol 36:141-145, Caroscio,J.T.,et al, 1986
Controlled Trial of Thyrotropin Releasing Hormone in Amyotrophic Lateral Sclerosis
Neurol 36:146-151, Brooke,M.H.,et al, 1986
Amyotrophic Lateral Sclerosis:Effects of Administration of Thyrotropin-Releasing Hormone
Neurol 36:152-159, Mitsumoto,H.,et al, 1986
Amyotrophic Lateral Sclerosis:A Double-Blind Crossover Trial of Thyrotropin-Releasing Hormone
JNNP 47:1332-1334, Imoto,K.,et al, 1984
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Treating Hearing Loss with Hearing Aids for the Prevention of Cognitive Decline and Dementia
Neurol 106:e214572, Cribb,L.,et al, 2026
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Deep Venous Dural Arteriovenous Fistula Mimicking Progressive Dementia
Stroke 57:e180-181, Langlois-Therien,T.,et al, 2026
Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026
Niemann-Pick Disease Type C
Gene Reviews www.genereview.org, Bremova-Ertl,T. & Patterson, M., 2025
A 59-Year-Old Female Patient with Urinary Dysfunction and Lightheadedness
Neurol 105:e214233, Bu,S.,et al, 2025
A 16-Year-Old Adolescent Boy with Ophthalmoplegia and Unilateral Ptosis
Neurol 105:e214430, Lu,Y.,, 2025
Clinodactyly as a Key Finding in Distal Spinal Muscular Atrophy
Neurol 104: e213682, Hayakawa,I.,et al, 2025
Pan-Neurofascin Nodo-Paranodopathy Presenting as Fulminant Guillain-Barre Syndrome
Neurol 105:e213848, Cabral,A.,et al, 2025
Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025
Infantile Epileptic Spasms Syndrome (West Syndrome)
Stat Pearls PMID:30725936, Smith,M.S.,et al, 2025
Unmasking Cerebrotendinous Xanthomatosis, Clinical Recognition of a Treatable Cause of Progressive Ataxia
Neurol 105:e214099, Mizutani,H.,et al, 2025
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025
A 19-Year-Old Woman with Progressive Weakness and Numbness in Her Arms and Legs
Neurol 104:e213495, Alsabah,A-A.,et al, 2025
A 60-Year-Old Man with Weakness and Gait Dysfunction
JAMA Neurol 82:305-306, Jones,F.J.S.,et al, 2025